Previous close | 330.54 |
Open | 330.63 |
Bid | 304.29 x 200 |
Ask | 357.31 x 200 |
Day's range | 330.47 - 330.87 |
52-week range | 157.00 - 331.58 |
Volume | |
Avg. volume | 1,107,980 |
Market cap | 12.412B |
Beta (5Y monthly) | 0.88 |
PE ratio (TTM) | 77.59 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Shockwave Medical's (SWAV) first-quarter results reflect robust revenue growth and gross margin expansion amid JNJ entering into a definitive agreement to acquire the company.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Insightful Analysis of Shockwave Medical's Position in the Cardiovascular Device Market